<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Lipids Health Dis</journal-id><journal-id journal-id-type="iso-abbrev">Lipids Health Dis</journal-id><journal-title-group><journal-title>Lipids in Health and Disease</journal-title></journal-title-group><issn pub-type="epub">1476-511X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25081826</article-id><article-id pub-id-type="pmc">4237891</article-id><article-id pub-id-type="publisher-id">1476-511X-13-121</article-id><article-id pub-id-type="doi">10.1186/1476-511X-13-121</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Hellhammer</surname><given-names>Juliane</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hellhammer@daacro.de</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Vogt</surname><given-names>Dominic</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>vogt@daacro.de</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Franz</surname><given-names>Nadin</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>franz@daacro.de</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Freitas</surname><given-names>Ulla</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>ulla.freitas@lonza.com</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Rutenberg</surname><given-names>David</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>d.rutenberg@lipogen.co.il</email></contrib></contrib-group><aff id="I1"><label>1</label>Diagnostic Assessment and Clinical Research Organization (Daacro) GmbH &#x00026; Co. KG, Science Park Trier, Max-Planck-Str. 22, 54296 Trier, Germany</aff><aff id="I2"><label>2</label>Lonza Ltd, Muenchensteinerstr. 38, 4002 Basel, Switzerland</aff><aff id="I3"><label>3</label>Lipogen Ltd, P.O.Box 7687, 31078 Haifa, Israel</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>31</day><month>7</month><year>2014</year></pub-date><volume>13</volume><fpage>121</fpage><lpage>121</lpage><history><date date-type="received"><day>16</day><month>5</month><year>2014</year></date><date date-type="accepted"><day>21</day><month>7</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Hellhammer et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Hellhammer et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.lipidworld.com/content/13/1/121"/><abstract><sec><title>Background</title><p>Supplementation with a phosphatidylserine and phosphatidylserine/ phosphatidic acid complex (PAS) has been observed to normalize stress induced dysregulations of the hypothalamus-pituitary-adrenal axis (HPAA). Prolonged stress first induces a hyper-activation of the HPAA, which then can be followed by a state of hypo-activation.</p><p>The aim of this study was to examine effects of an oral supplementation with 400&#x000a0;mg PS &#x00026; 400&#x000a0;mg PA (PAS 400) per day on the endocrine stress response (ACTH, saliva and serum cortisol) to a psychosocial stressor. A special focus was to analyze subgroups of low versus high chronically stressed subjects as well as to test efficacy of 200&#x000a0;mg PS &#x00026; 200&#x000a0;mg PA (PAS 200).</p></sec><sec><title>Methods</title><p>75 healthy male volunteers were enrolled for this double-blind, placebo-controlled study, stratified by chronic stress level, and randomly allocated to one of three study arms (placebo, PAS 200 and PAS 400 per day, respectively). Study supplementation was administered for 42 days for each participant. Chronic stress was measured with the Trier Inventory for Chronic Stress (TICS), and subgroups of high and low chronic stress were differentiated by median values as provided by the TICS authors. A six week period of supplementation was followed by an acute stress test (Trier Social Stress Test - TSST).</p></sec><sec><title>Results</title><p>Chronic stress levels and other baseline measures did not differ between treatment groups (all p&#x02009;&#x0003e;&#x02009;0.05). Acute stress was successfully induced by the TSST and resulted in a hyper-responsivity of the HPAA in chronically stressed subjects. Compared to placebo, a supplementation with a daily dose of PAS 400 was effective in normalizing the ACTH (p&#x02009;=&#x02009;0.010), salivary (p&#x02009;=&#x02009;0.043) and serum cortisol responses (p&#x02009;=&#x02009;0.035) to the TSST in chronically high but not in low stressed subjects (all p&#x02009;&#x0003e;&#x02009;0.05). Compared to placebo, supplementation with PAS 200 did not result in any significant differences in these variables (all p&#x02009;&#x0003e;&#x02009;0.05). There were no significant effects of supplementation with PAS on heart rate, pulse transit time, or psychological stress response (all p&#x02009;&#x0003e;&#x02009;0.05).</p></sec><sec><title>Conclusion</title><p>In chronically stressed subjects, a supplementation with PAS 400 (MemreePlus&#x02122;) can normalize the hyper-responsivity of the HPAA to an acute stressor.</p></sec><sec><title>Trial registration</title><p>Trial registration: DRKS-ID: <ext-link ext-link-type="uri" xlink:href="https://drks-neu.uniklinik-freiburg.de/drks_web/navigate.do?navigationId=results">DRKS00005125</ext-link></p></sec></abstract><kwd-group><kwd>Phosphatidylserine</kwd><kwd>Phosphatidic acid</kwd><kwd>Memree</kwd><kwd>Stress</kwd><kwd>PAS</kwd><kwd>Cortisol</kwd><kwd>Acute stress</kwd><kwd>Chronic stress</kwd><kwd>Stress response</kwd><kwd>TSST</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Stress is an individual response to external and internal challenges ranging from behavioral to molecular adaptions, affecting the stress response network in the central nervous system and its crosstalk with peripheral organs via the endocrine and the autonomic nervous systems [<xref ref-type="bibr" rid="B1">1</xref>]. The hypothalamic-pituitary-adrenal axis (HPAA) plays a central role in such adaptation processes of the organism [<xref ref-type="bibr" rid="B2">2</xref>]. In response to acute stressors, the hypothalamus secretes corticotropin&#x02013;releasing factor, which triggers the release of adrenocorticotropic hormone (ACTH) from the pituitary gland. ACTH then promotes the release of cortisol from the adrenal cortex. Cortisol affects numerous physiological functions, such as carbohydrate, lipid and protein metabolism, the immune system, and enhances the energy supply of the central nervous system. Chronic psychological stress has been shown to induce dysregulations of the HPAA, which are associated with impaired psychological and somatic well-being. Under such conditions, a biphasic response of the HPAA has been observed: prolonged psychological stress may first induce a hyper-activation of the HPAA, which may then be followed by a state of hypo-activation [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. While a hyper-activation of the HPAA has been shown to be associated with stress related disorders such as melancholic depression, anxiety disorders, and metabolic syndrome, a hypo-activation is rather linked to fatigue, pain, irritability and associated disorders such as fibromyalgia, arthritis, and chronic fatigue syndrome [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. Thus, a hyper-activation of the HPAA seems to be associated with a hyper-reactivity to acute stress, while a reduced synthesis of cortisol may mainly account for a hypoactive state [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B12">12</xref>].</p><p>Recent research showed that the intake of certain nutraceuticals reversed or normalized such dysregulations and improved stress symptomatology. For example, the intake of fertilized egg powder for the duration of four weeks normalized the psychological and physiological stress response in chronically stressed but otherwise healthy males [<xref ref-type="bibr" rid="B13">13</xref>]. Moreover, studies on different substances enriched with phospholipids have shown beneficial effects in chronically stressed subjects. It has been suggested that milk phospholipids may increase cortisol availability in subjects with high chronic stress [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Phosphatidic acid (PA) is one of the most important glycerophospholipids found in bio-membranes. PA has different roles in the cell: it is a precursor for other lipids such as phosphatidylserine (PS) or phosphatidylcholine via the conversion of PA to diacylglycerol [<xref ref-type="bibr" rid="B16">16</xref>]. Moreover, PA influences membrane curvature [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>] and acts as signaling lipid [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. Animal research suggests that PA may prevent or restore gastrointestinal disorders [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>] and may increase skeletal muscle mass [<xref ref-type="bibr" rid="B23">23</xref>]. PS plays a key role in neuronal cell structure and functioning and may improve memory, learning, mood and stress management [<xref ref-type="bibr" rid="B24">24</xref>-<xref ref-type="bibr" rid="B29">29</xref>]. PS has been shown to decrease ACTH and cortisol responses to acute physical and mental stress [<xref ref-type="bibr" rid="B30">30</xref>-<xref ref-type="bibr" rid="B35">35</xref>]. Additionally, the intake of PS has been associated with an improvement of psychiatric disorders, such as bipolar and major depressive disorders reviewed in [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B36">36</xref>], as well as with the prevention of inflammatory neurodegenerative events [<xref ref-type="bibr" rid="B37">37</xref>].</p><p>Moreover, in combination with PS, PA has been shown to reduce cortisol levels and enhance well-being under acute social stress. In a previous study, we could show that the administration of PAS 400 per day over a period of 21&#x000a0;days resulted in both a significant decrease of the ACTH- and cortisol-response, and, in addition, a reduction of anxiety to the TSST [<xref ref-type="bibr" rid="B27">27</xref>]. The exact mechanisms on how PA and PS contribute to an adaptation of the stress response network are still unknown. Several stress-related disorders such as depression and mood disorders have been associated with fatty acid deficiencies [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B38">38</xref>-<xref ref-type="bibr" rid="B41">41</xref>]. The intake of dietary phospholipids such as PA and PS may cause alterations and optimize the composition of cell membranes which in turn may modulate cellular function and activity of membrane [<xref ref-type="bibr" rid="B42">42</xref>].</p><p>The aim of the current study was to confirm the HPAA normalizing effects of a dose of PAS 400 found in a previous study. Here, we were especially interested whether there was a difference in effects between chronically stressed or non-stressed people. Chronic stress was assessed by using the screening scale for chronic stress of the Trier Inventory for Chronic Stress (TICS) [<xref ref-type="bibr" rid="B43">43</xref>]. Cut-off for low versus high chronic stress was defined as provided by a norm population of the TICS authors. In addition, we wanted to investigate whether these effects can also be observed with a lower dosage of PAS 200. In order to investigate PAS effects in a homogeneous study population, we included only male subjects and enlarged group size. We investigated the effects of two different doses of PAS (200 mg PA &#x00026; 200 mg PS and 400 mg PA &#x00026; 400 mg PS per day) over 42 days compared to placebo on psychological and physiological stress reactivity in subjects stratified by low and high chronic stress levels.</p></sec><sec sec-type="results"><title>Results</title><sec><title>Baseline measures</title><p>Groups did not differ with respect to age, height, body mass, BMI (body mass index), WHR (waist to hip ratio), systolic blood pressure, diastolic blood pressure and heart rate (Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>). Furthermore, no baseline differences were observed for measures of chronic stress (Trier Inventory of Chronic Stress; TICS; all p&#x02009;&#x0003e;&#x02009;0.05; data not shown) between all three treatment groups.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Baseline measures</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="center">&#x000a0;</th><th align="center"><bold>Age [years]</bold></th><th align="center"><bold>Height [m]</bold></th><th align="center"><bold>Body mass [kg]</bold></th><th align="center"><bold>BMI [kg/m</bold><sup>
<bold>2</bold>
</sup><bold>]</bold></th><th align="center"><bold>WHR</bold></th><th align="center"><bold>Systolic blood pressure [mmHG]</bold></th><th align="center"><bold>Diastolic blood pressure [mmHG]</bold></th><th align="center"><bold>Heart rate [bpm]</bold></th></tr></thead><tbody valign="top"><tr><td colspan="2" align="center" valign="bottom"><bold>Placebo group</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Mean<hr/></td><td align="center" valign="bottom">26.64<hr/></td><td align="center" valign="bottom">1.81<hr/></td><td align="center" valign="bottom">83.68<hr/></td><td align="center" valign="bottom">25.45<hr/></td><td align="center" valign="bottom">0.86<hr/></td><td align="center" valign="bottom">127.64<hr/></td><td align="center" valign="bottom">71.08<hr/></td><td align="center" valign="bottom">69.16<hr/></td></tr><tr><td align="center" valign="bottom">SE<hr/></td><td align="center" valign="bottom">1.48<hr/></td><td align="center" valign="bottom">0.02<hr/></td><td align="center" valign="bottom">2.26<hr/></td><td align="center" valign="bottom">0.56<hr/></td><td align="center" valign="bottom">0.01<hr/></td><td align="center" valign="bottom">2.08<hr/></td><td align="center" valign="bottom">1.64<hr/></td><td align="center" valign="bottom">1.89<hr/></td></tr><tr><td align="center" valign="bottom">N<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">24<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td></tr><tr><td colspan="5" align="center" valign="bottom"><bold>PAS 200 group</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Mean<hr/></td><td align="center" valign="bottom">25.92<hr/></td><td align="center" valign="bottom">1.82<hr/></td><td align="center" valign="bottom">84.8<hr/></td><td align="center" valign="bottom">25.59<hr/></td><td align="center" valign="bottom">0.86<hr/></td><td align="center" valign="bottom">131.68<hr/></td><td align="center" valign="bottom">73.64<hr/></td><td align="center" valign="bottom">73.32<hr/></td></tr><tr><td align="center" valign="bottom">SE<hr/></td><td align="center" valign="bottom">1.32<hr/></td><td align="center" valign="bottom">0.02<hr/></td><td align="center" valign="bottom">3.11<hr/></td><td align="center" valign="bottom">0.73<hr/></td><td align="center" valign="bottom">0.01<hr/></td><td align="center" valign="bottom">1.5<hr/></td><td align="center" valign="bottom">2.11<hr/></td><td align="center" valign="bottom">2.49<hr/></td></tr><tr><td align="center" valign="bottom">N<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td></tr><tr><td colspan="5" align="center" valign="bottom"><bold>PAS 400 group</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Mean<hr/></td><td align="center" valign="bottom">26.48<hr/></td><td align="center" valign="bottom">1.83<hr/></td><td align="center" valign="bottom">85.2<hr/></td><td align="center" valign="bottom">25.59<hr/></td><td align="center" valign="bottom">0.87<hr/></td><td align="center" valign="bottom">129.12<hr/></td><td align="center" valign="bottom">73.56<hr/></td><td align="center" valign="bottom">71.2<hr/></td></tr><tr><td align="center" valign="bottom">SE<hr/></td><td align="center" valign="bottom">1.37<hr/></td><td align="center" valign="bottom">0.01<hr/></td><td align="center" valign="bottom">2.32<hr/></td><td align="center" valign="bottom">0.8<hr/></td><td align="center" valign="bottom">0.01<hr/></td><td align="center" valign="bottom">2.52<hr/></td><td align="center" valign="bottom">2.39<hr/></td><td align="center" valign="bottom">2.84<hr/></td></tr><tr><td align="center" valign="bottom">N<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td><td align="center" valign="bottom">25<hr/></td></tr><tr><td colspan="3" align="center" valign="bottom"><bold>Group differences</bold><sup>
<bold>a</bold>
</sup><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x003c7;<sup>2</sup><hr/></td><td align="center" valign="bottom">0.077<hr/></td><td align="center" valign="bottom">0.250<hr/></td><td align="center" valign="bottom">0.684<hr/></td><td align="center" valign="bottom">0.252<hr/></td><td align="center" valign="bottom">0.550<hr/></td><td align="center" valign="bottom">2,717<hr/></td><td align="center" valign="bottom">1,011<hr/></td><td align="center" valign="bottom">1,758<hr/></td></tr><tr><td align="center" valign="bottom">df<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom">2<hr/></td></tr><tr><td align="center">p</td><td align="center">0.962</td><td align="center">0.882</td><td align="center">0.711</td><td align="center">0.882</td><td align="center">0.760</td><td align="center">0.257</td><td align="center">0.603</td><td align="center">0.415</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>based on Kruskal Wallis H test.</p><p>PAS 200 group: 200&#x000a0;mg PA &#x00026; 200&#x000a0;mg PS per day; PAS 400 group: 400&#x000a0;mg PA &#x00026; 400&#x000a0;mg PS per day.</p><p>PA&#x02009;=&#x02009;phosphatidic acid, PS&#x02009;=&#x02009;phosphatidylserine, mg&#x02009;=&#x02009;milligrams, m&#x02009;=&#x02009;meter, kg&#x02009;=&#x02009;kilograms, mmHG&#x02009;=&#x02009;millimeter of mercury, bpm&#x02009;=&#x02009;beats per minute, SE&#x02009;=&#x02009;Standard Error, N&#x02009;=&#x02009;Sample Size.</p></table-wrap-foot></table-wrap></sec><sec><title>Compliance</title><p>Mean overall compliance was about 89.65% (SE&#x02009;=&#x02009;1.30%) as assessed by a medication event monitoring system (MEMS&#x000ae;) and about 95.31% (SE&#x02009;=&#x02009;0.62%) as assessed by counting of returned capsules. Analyses for covariance were performed to explore the potential influence of compliance on outcome measures. Neither MEMS&#x000ae; data nor counting the returned capsules showed an effect of compliance on ACTH, serum cortisol or saliva cortisol response to the TSST (all p&#x02009;&#x0003e;&#x02009;0.05, data not shown).</p></sec><sec><title>Stress responsivity</title><p>Acute stress was induced by the Trier Social Stress Test (TSST). Induction of acute stress was confirmed by significant time effects in repeated measures analyses of variance for relevant variables. As expected, the TSST induced a pronounced increase in salivary cortisol, serum cortisol, and ACTH levels as well as heart rate and a decrease of pulse transit time (PTT) (see Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>). The PTT is determined by the R wave of the heart beat to the pulse wave arrival at the finger. PTT is used as an index for arterial blood pressure [<xref ref-type="bibr" rid="B44">44</xref>-<xref ref-type="bibr" rid="B46">46</xref>] and as a biomarker for stress reactivity. Acute stress is associated with an increased blood pressure and a reduced PTT [<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B48">48</xref>].</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Biological stress response</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="left">&#x000a0;</th><th align="center"><bold>Heart rate</bold></th><th align="center"><bold>Pulse transit time</bold></th><th align="center"><bold>Saliva Cortisol</bold></th><th align="center"><bold>Serum Cortisol</bold></th><th align="center"><bold>ACTH</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">F<hr/></td><td align="center" valign="bottom">130.94<hr/></td><td align="center" valign="bottom">209.66<hr/></td><td align="center" valign="bottom">116.270<hr/></td><td align="center" valign="bottom">116.27<hr/></td><td align="center" valign="bottom">199.22<hr/></td></tr><tr><td align="left" valign="bottom">df, error df<hr/></td><td align="center" valign="bottom">1.98, 124.52<hr/></td><td align="center" valign="bottom">2.74, 147.89<hr/></td><td align="center" valign="bottom">2.10, 128.00<hr/></td><td align="center" valign="bottom">2.10, 128.0<hr/></td><td align="center" valign="bottom">1, 60<hr/></td></tr><tr><td align="left" valign="bottom">p<hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td></tr><tr><td align="left">&#x003b7;<sub>p</sub><sup>&#x02009;&#x02009;&#x02009;2</sup></td><td align="center">0.675</td><td align="center">0.795</td><td align="center">0.656</td><td align="center">0.656</td><td align="center">0.769</td></tr></tbody></table><table-wrap-foot><p>Significant p-values are written in bold letters.</p><p>ACTH&#x02009;=&#x02009;adrenocorticotropic hormone.</p></table-wrap-foot></table-wrap><p>Furthermore, subjects showed an increase of state anxiety (STAI: State-trait-anxiety inventory; VAS: visual analogue scales), perceived stress, insecurity (VAS), and negative mood (MDBF: Multidimensional mood state questionnaire) (Table&#x000a0;<xref ref-type="table" rid="T3">3</xref>).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Psychological stress response</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom"><bold>MDBF</bold><hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom"><bold>STAI</bold><hr/></th><th align="center" valign="bottom"><bold>VAS</bold><hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th></tr><tr><th align="left">&#x000a0;</th><th align="center"><bold>good mood</bold></th><th align="center"><bold>alertness</bold></th><th align="center"><bold>calmness</bold></th><th align="center"><bold>state anxiety</bold></th><th align="center"><bold>stress</bold></th><th align="center"><bold>anxiety</bold></th><th align="center"><bold>insecurity</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">F<hr/></td><td align="center" valign="bottom">42.04<hr/></td><td align="center" valign="bottom">28.22<hr/></td><td align="center" valign="bottom">74.43<hr/></td><td align="center" valign="bottom">64.13<hr/></td><td align="center" valign="bottom">49.96<hr/></td><td align="center" valign="bottom">34.46<hr/></td><td align="center" valign="bottom">67.95<hr/></td></tr><tr><td align="left" valign="bottom">df, error df<hr/></td><td align="center" valign="bottom">1, 65<hr/></td><td align="center" valign="bottom">1, 64<hr/></td><td align="center" valign="bottom">1, 64<hr/></td><td align="center" valign="bottom">1, 65<hr/></td><td align="center" valign="bottom">2, 128<hr/></td><td align="center" valign="bottom">1.81, 117.83<hr/></td><td align="center" valign="bottom">2, 130<hr/></td></tr><tr><td align="left" valign="bottom">p<hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td><td align="center" valign="bottom"><bold>&#x0003c; 0.001</bold><hr/></td></tr><tr><td align="left">&#x003b7;<sub>p</sub><sup>&#x02009;&#x02009;&#x02009;2</sup></td><td align="center">0.393</td><td align="center">0.306</td><td align="center">0.538</td><td align="center">0.497</td><td align="center">0.438</td><td align="center">0.346</td><td align="center">0.511</td></tr></tbody></table><table-wrap-foot><p>Significant p-values are written in bold letters.</p><p>STAI&#x02009;=&#x02009;state trait anxiety inventory, MDBF&#x02009;=&#x02009;multidimensional mood state questionnaire, VAS&#x02009;=&#x02009;visual analogue scale.</p></table-wrap-foot></table-wrap></sec><sec><title>Treatment effects</title><p>We compared differences between treatment groups (placebo, PAS 200 and PAS 400) and between subjects scoring either high or low on a chronic stress inventory (TICS). To compare general cortisol levels and cortisol increases, we calculated the area under the curve with respect to ground (AUC<sub>G</sub>) and its increase (AUC<sub>I</sub>) as described by Pruessner and colleagues [<xref ref-type="bibr" rid="B49">49</xref>]. The AUC<sub>G</sub> provides information on general cortisol levels whereas the AUC<sub>I</sub> on cortisol increase and reactivity.</p><sec><title>Treatment group</title><p>Neither supplementation of PAS 200 nor of PAS 400 resulted in significant effects on saliva or serum cortisol levels on the overall study population (saliva cortisol: AUC<sub>G</sub>: &#x003c7;<sup>2</sup><sub>&#x02009;&#x02009;2</sub>&#x02009;=&#x02009;0.44, p&#x02009;=&#x02009;0.801; AUC<sub>I</sub>: &#x003c7;<sup>2</sup><sub>&#x02009;&#x02009;2</sub>&#x02009;=&#x02009;2.01, p&#x02009;=&#x02009;0.366; serum cortisol: AUC<sub>G</sub>: F<sub>2, 61</sub>&#x02009;=&#x02009;0.56, p&#x02009;=&#x02009;0.576; AUC<sub>I</sub>: F<sub>2, 59</sub>&#x02009;=&#x02009;2.19, p&#x02009;=&#x02009;0.121). For ACTH responses there was a significant main effect of treatment group (F<sub>2, 59</sub>&#x02009;=&#x02009;3.66, p&#x02009;=&#x02009;0.032). Tukey post hoc tests revealed significant lower ACTH levels in the PAS 400 group compared to the PAS 200 group (p&#x02009;=&#x02009;0.025).</p></sec><sec><title>Chronic stress level</title><p>Furthermore, no significant main effect of chronic stress was observed for ACTH increases (F<sub>1, 59</sub>&#x02009;=&#x02009;1.820, p&#x02009;=&#x02009;0.182), AUC<sub>G</sub> saliva cortisol (Z&#x02009;=&#x02009;&#x02212;0.28, p&#x02009;=&#x02009;0.783), and AUC<sub>G</sub> serum cortisol (F1, 61&#x02009;=&#x02009;0.14, p&#x02009;=&#x02009;0.721). However, high chronically stressed subjects (HCS) showed a tendency towards higher saliva cortisol AUC<sub>I</sub> (Z&#x02009;=&#x02009;&#x02212;1.70, p&#x02009;=&#x02009;0.089) and significantly higher serum cortisol AUC<sub>I</sub> (F1, 59&#x02009;=&#x02009;13.05, p&#x02009;=&#x02009;0.001) than low chronically stressed subjects (LCS).</p></sec><sec><title>Subgroup analysis</title><p>To further explore the impact of chronic stress levels on treatment effects, we compared subgroups of HCS and LCS.</p><p>HCS of the PAS 400 group showed significantly lower increases of ACTH, serum cortisol, and saliva cortisol as compared to the placebo and the PAS 200 group. These effects could not be shown in LCS of the PAS 400 group. Also, no differences were observed for HCS and LCS of the PAS 200 group as compared to placebo. This suggests that a supplementation with PAS 400 normalized the enhanced ACTH- and cortisol-responses to an acute stressor in subjects reporting a chronic stress load (Figures&#x000a0;<xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F3">3</xref>). The statistical information on effects of PAS on the endocrine stress response is provided in Table&#x000a0;<xref ref-type="table" rid="T4">4</xref> for both HCS and LCS. Comparable to our previous study [<xref ref-type="bibr" rid="B27">27</xref>], no effects of supplementation were found for autonomic (heart rate; pulse transit time) and for psychological response measures (mood, insecurity, perceived stress) in both low and high chronically stressed subjects (data not shown). While we observed significant dampening effects on anxiety in the first study, this effect was only marginal in the present study (p&#x02009;&#x0003c;&#x02009;0.07).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>ACTH response to acute stress; *p&#x02009;&#x0003c;&#x02009;0.05.</bold><italic>PAS 200 group: 200&#x000a0;mg PA &#x00026; 200&#x000a0;mg PS per day; PAS 400 group: 400&#x000a0;mg PA &#x00026; 400&#x000a0;mg PS per day.</italic></p></caption><graphic xlink:href="1476-511X-13-121-1"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Serum cortisol response to acute stress; *p&#x02009;&#x0003c;&#x02009;0.05.</bold><italic>PAS 200 group: 200&#x000a0;mg PA &#x00026; 200&#x000a0;mg PS per day; PAS 400 group: 400&#x000a0;mg PA &#x00026; 400&#x000a0;mg PS per day.</italic></p></caption><graphic xlink:href="1476-511X-13-121-2"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Saliva cortisol response to acute stress; *p&#x02009;&#x0003c;&#x02009;0.05.</bold><italic>PAS 200 group: 200&#x000a0;mg PA &#x00026; 200&#x000a0;mg PS per day; PAS 400 group: 400&#x000a0;mg PA &#x00026; 400&#x000a0;mg PS per day.</italic></p></caption><graphic xlink:href="1476-511X-13-121-3"/></fig><table-wrap position="float" id="T4"><label>Table 4</label><caption><p><bold>Statistical information on group differences for AUC</bold><sub>
<bold>G </bold>
</sub><bold>and AUC</bold><sub>
<bold>I </bold>
</sub><bold>for salivary cortisol, serum cortisol and ACTH levels in response to acute stress</bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="left">&#x000a0;</th><th colspan="3" align="center"><bold>low stressed subjects</bold></th><th colspan="3" align="center"><bold>high stressed subjects</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><bold>salivary cortisol</bold><sup>
<bold>a</bold>
</sup><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x003c7;<sup>2</sup><hr/></td><td align="center" valign="bottom">df<hr/></td><td align="center" valign="bottom">p<hr/></td><td align="center" valign="bottom">&#x003c7;<sup>2</sup><hr/></td><td align="center" valign="bottom">df<hr/></td><td align="center" valign="bottom">p<hr/></td></tr><tr><td align="left" valign="bottom">AUC<sub>G</sub><hr/></td><td align="center" valign="bottom">1.32<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom">0.518<hr/></td><td align="center" valign="bottom">0.82<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom">0.664<hr/></td></tr><tr><td align="left" valign="bottom">AUC<sub>I</sub><hr/></td><td align="center" valign="bottom">0.43<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom">0.805<hr/></td><td align="center" valign="bottom">6.48<hr/></td><td align="center" valign="bottom">2<hr/></td><td align="center" valign="bottom"><bold>0.039</bold><hr/></td></tr><tr><td colspan="3" align="left" valign="bottom"><italic>Post hoc testing AUC</italic><sub>
<italic>I</italic>
</sub><italic>in high stressed subjects</italic><sup>
<italic>b</italic>
</sup><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom"><italic>Z</italic><hr/></td><td align="center" valign="bottom"><italic>p</italic><hr/></td><td align="center" valign="bottom"><italic>r</italic><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><italic>PAS 400 group vs. Placebo group</italic><hr/></td><td align="center" valign="bottom"><italic>&#x02212;1.97</italic><hr/></td><td align="center" valign="bottom"><bold>
<italic>0.049</italic>
</bold><hr/></td><td align="center" valign="bottom"><italic>0.41</italic><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><italic>PAS 400 group vs. PAS 200 group</italic><hr/></td><td align="center" valign="bottom"><italic>&#x02212;2.37</italic><hr/></td><td align="center" valign="bottom"><bold>
<italic>0.018</italic>
</bold><hr/></td><td align="center" valign="bottom"><italic>0.51</italic><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><italic>PAS 200 group vs. Placebo group</italic><hr/></td><td align="center" valign="bottom"><italic>&#x02212;0.21</italic><hr/></td><td align="center" valign="bottom"><italic>0.833</italic><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><bold>serum cortisol</bold><sup>
<bold>c</bold>
</sup><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">F<hr/></td><td align="center" valign="bottom">df, error df<hr/></td><td align="center" valign="bottom">p<hr/></td><td align="center" valign="bottom">F<hr/></td><td align="center" valign="bottom">df, error df<hr/></td><td align="center" valign="bottom">p<hr/></td></tr><tr><td align="left" valign="bottom">AUC<sub>G</sub><hr/></td><td align="center" valign="bottom">0.44<hr/></td><td align="center" valign="bottom">2, 31<hr/></td><td align="center" valign="bottom">0.651<hr/></td><td align="center" valign="bottom">0.55<hr/></td><td align="center" valign="bottom">2, 30<hr/></td><td align="center" valign="bottom">0.585<hr/></td></tr><tr><td align="left" valign="bottom">AUC<sub>I</sub><hr/></td><td align="center" valign="bottom">0.09<hr/></td><td align="center" valign="bottom">2, 31<hr/></td><td align="center" valign="bottom">0.911<hr/></td><td align="center" valign="bottom">4.87<hr/></td><td align="center" valign="bottom">2, 28<hr/></td><td align="center" valign="bottom"><bold>0.015</bold><hr/></td></tr><tr><td colspan="3" align="left" valign="bottom"><italic>Post hoc testing AUC</italic><sub>
<italic>I</italic>
</sub><italic>in high stressed subjects</italic><sup>
<italic>d</italic>
</sup><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom"><italic>p</italic><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><italic>PAS 400 group vs. Placebo group</italic><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom"><bold>
<italic>0.035</italic>
</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><italic>PAS 400 group vs. PAS 200 group</italic><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom"><bold>
<italic>0.033</italic>
</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><italic>PAS 200 group vs. Placebo group</italic><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom"><italic>0.995</italic><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><bold>ACTH</bold><sup>
<bold>e</bold>
</sup><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">F<hr/></td><td align="center" valign="bottom">df, error df<hr/></td><td align="center" valign="bottom">p<hr/></td><td align="center" valign="bottom">F<hr/></td><td align="center" valign="bottom">df, error df<hr/></td><td align="center" valign="bottom">p<hr/></td></tr><tr><td align="left" valign="bottom">group difference<hr/></td><td align="center" valign="bottom">1.60<hr/></td><td align="center" valign="bottom">2, 30<hr/></td><td align="center" valign="bottom">0.218<hr/></td><td align="center" valign="bottom">2.43<hr/></td><td align="center" valign="bottom">2, 29<hr/></td><td align="center" valign="bottom">0.106<hr/></td></tr><tr><td align="left" valign="bottom">increase differences<hr/></td><td align="center" valign="bottom">0.31<hr/></td><td align="center" valign="bottom">2, 30<hr/></td><td align="center" valign="bottom">0.737<hr/></td><td align="center" valign="bottom">4.54<hr/></td><td align="center" valign="bottom">2, 29<hr/></td><td align="center" valign="bottom"><bold>0.019</bold><hr/></td></tr><tr><td colspan="3" align="left" valign="bottom"><italic>Post hoc testing ACTH increase in high stressed subjects</italic><sup>
<italic>e</italic>
</sup><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom"><italic>F</italic><hr/></td><td align="center" valign="bottom"><italic>df, error df</italic><hr/></td><td align="center" valign="bottom"><italic>p</italic><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><italic>PAS 400 group vs. Placebo group</italic><hr/></td><td align="center" valign="bottom"><italic>8.22</italic><hr/></td><td align="center" valign="bottom"><italic>1, 19</italic><hr/></td><td align="center" valign="bottom"><bold>
<italic>0.010</italic>
</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom"><italic>PAS 400 group vs. PAS 200 group</italic><hr/></td><td align="center" valign="bottom"><italic>8.23</italic><hr/></td><td align="center" valign="bottom"><italic>1, 20</italic><hr/></td><td align="center" valign="bottom"><bold>
<italic>0.009</italic>
</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left"><italic>PAS 200 group vs. Placebo group</italic></td><td align="center"><italic>0.25</italic></td><td align="center"><italic>1, 19</italic></td><td align="center"><italic>0.627</italic></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p>PAS 200 group: 200&#x000a0;mg PA &#x00026; 200&#x000a0;mg PS per day; PAS 400 group: 400&#x000a0;mg PA &#x00026; 400&#x000a0;mg PS per day.</p><p>Significant p-values are written in bold letters. Post hoc analyses are written in italic letters, ACTH&#x02009;=&#x02009;adrenocorticotropic hormone.</p><p><sup>
<italic>a</italic>
</sup><italic>statistics based on Kruskal Wallis H Test.</italic></p><p><sup>
<italic>b</italic>
</sup><italic>statistics based on Mann&#x02013;Whitney U test.</italic></p><p><sup>
<italic>c</italic>
</sup><italic>statistics based on univariate analysis of variance.</italic></p><p><sup>
<italic>d</italic>
</sup><italic>statistics based on Tukey post hoc testing.</italic></p><p><sup>
<italic>e</italic>
</sup><italic>statistics based on repeated measures analysis of variance.</italic></p></table-wrap-foot></table-wrap></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>In the present study, we investigated the effects of a 42-day dose-dependent intake of PAS on biological and psychological responses to the TSST in both HCS and LCS. As expected, the TSST reliably induced robust biological and psychological stress responses. Perceived stress responses were similar in all treatment groups. The placebo group showed a slight tendency for higher anxiety (VAS) during the TSST as compared to the PAS groups. Compliance assessed by MEMS&#x000ae; (about 90%) and by counting remaining capsules (about 95%) was rather high. Differences between both might have been caused by subjects taking their daily dose along to work with only one opening of the track cap which then results in a lower number of total openings. In that case the number of openings as assessed by MEMS&#x000ae; does not reflect the number of intake occasions.</p><p>A pronounced stress dampening effect of PAS on HPAA responses could only be observed for the 400&#x000a0;mg treatment group in HCS. These data confirm our previous findings, and are in line with other studies showing that acute and chronic administration of PS and PAS can normalize cortisol responses to acute physical and mental stress [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B30">30</xref>-<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>].</p><p>As addressed in the introduction, chronic stress can first induce a hyper- and then a subsequent hypo-cortisolemic state. Phospholipid effects on the HPAA can best be described in terms of a normalization of stress responsivity. If chronic stress results in a hyper-responsivity of the HPAA, as observed in this and other studies [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B27">27</xref>], phospholipids can be expected to buffer the HPAA response to stress. On the other hand, phospholipids may restore normal ACTH- and cortisol responses to stress in subjects with a reduced HPAA response [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Notably, relaxation and stress management techniques show similar effects [<xref ref-type="bibr" rid="B50">50</xref>-<xref ref-type="bibr" rid="B55">55</xref>]. These observations support the assumption that both phospholipids and relaxation can normalize the HPAA-responsivity to stress.</p><p>As in our previous PAS study, effects of PAS 400 could only be observed for endocrine but not for autonomic stress responses. If PAS would primarily affect the stress response network in the brain, one would expect common secondary effects on psychological, endocrine, and autonomic measures. This is unlikely, since in both studies psychological effects were inconsistent and autonomic effects could not be observed. This points to the possibility, that PAS primarily targets peripheral components of the HPAA. Chronic stress has been shown to reduce cortisol binding globulin (CBG) [<xref ref-type="bibr" rid="B56">56</xref>-<xref ref-type="bibr" rid="B58">58</xref>]. CBG is a glycoprotein synthesized in the liver and secreted in the blood where it binds with a high affinity but low capacity to glucocorticoid hormones, such as cortisol in humans and corticosterone in laboratory rodents. In mammals, 95% of circulating glucocorticoids are bound to either CBG (80%) or albumin (15%), and only the 5% free fraction is able to enter the brain [<xref ref-type="bibr" rid="B59">59</xref>]. During stress, the concentration of glucocorticoids rises significantly, and the free fraction increases even more, once CBG becomes saturated. However, glucocorticoids unbound to CBG are cleared from the blood more quickly. It is assumed that CBG plays an important role in the fast actions of glucocorticoids on behavior by maintaining a blood glucocorticoid pool that will be able to access the brain for the fast effects of glucocorticoids [<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B61">61</xref>].</p><p>The observed pronounced increase of ACTH and cortisol in the TSST can possibly be explained by a drop of CBG in chronically stressed subjects. If so, one may hypothesize that PAS 400 first causes a normalization of CBG levels under such conditions, which then would result in a normalization of the activity and reactivity of the HPAA.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In chronically stressed subjects, PAS 400 can be expected to buffer a hyper-responsivity of the HPAA to acute stressors by normalizing cortisol responses. In contrast, PAS 400 does not affect endocrine stress response in LCS who do not have elevated cortisol levels. Although sample sizes for subgroup analyses of chronic stress were rather small, the results of this study are intriguing.</p><p>The CBG-hypothesis, derived from this study, can now be tested to elucidate a possible relevant mechanism of the action of PAS. If this hypothesis holds true, an indication of PAS for stress related disorders is evident, particularly for disorders which are considered to occur in consequence of stress-elevated cortisol levels, such as cardiovascular disease, central obesity, and the metabolic syndrome [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B62">62</xref>]. In sum, we conclude that PAS 400 (MemreePlus&#x02122;) is a safe and effective supplement for the reduction of both physical and mental stress. Based on the previous study, it can be speculated that women also benefit from MemreePlus&#x02122; supplementation. This needs to be confirmed in further studies.</p><sec><title>Participants and methods</title><sec><title>Participant selection</title><p>Healthy, non-smoking male volunteers between age 20 and 45&#x000a0;years were recruited by newspaper advertisement and flyer distribution in the area of Trier, Germany. Subjects&#x02019; health was assessed in a structured medical interview by a study physician and by assessing clinical blood chemistry. Individuals were not eligible if any of the following criteria applied: known allergies to ingredients of the test substance, addiction to nicotine, drugs or alcohol, recent changes in nutritional habits (e.g. start of a weight loss diet), any serious general illness within the last 12&#x000a0;months, any febrile illness (longer than 24&#x000a0;hours) within seven days prior to assessment, any intake of antibiotics during the four weeks prior to study inclusion, diabetes mellitus, heart disease, hypertension, kidney disease, significant respiratory disease, or epilepsy, immunologic or infectious disease (e.g. hepatitis, tuberculosis, HIV or AIDS, lupus, rheumatoid arthritis) which could place the subject at risk or interfere with the accuracy of the study results, current or past participation in a TSST study, employee of the sponsor or CRO, medications that are likely to affect treatment response, or any conditions that may affect the ability of the individual to complete the study or the interpretation of the study results.A total number of 124 subjects were screened for study inclusion and exclusion criteria of which 75 male subjects met the eligibility criteria. These subjects were randomly assigned and stratified by chronic stress level to one of the three treatment groups (25 subjects per group: placebo, PAS 200, PAS 400). After study inclusion, one subject of the placebo group and two subjects of the PAS 200 group were lost to follow up, leaving 24 subjects of the placebo group, 23 subjects of the PAS 200 group, and 25 subjects of the PAS 400 group for analysis (total sample size of 72 subjects) (see Figure&#x000a0;<xref ref-type="fig" rid="F4">4</xref>). The study protocol was approved by the ethical review board of the Medical Association of Rhineland-Palatinate (Mainz, Germany), and written informed consent was obtained from all participants. The study was performed in accordance with the ethical principles that have their origin in the Declaration of Helsinki and are consistent with International Conference on Harmonization/Good Clinical Practice (2008).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Subject flow chart.</bold><italic>PAS 200 group: 200&#x000a0;mg PA &#x00026; 200&#x000a0;mg PS per day; PAS 400 group: 400&#x000a0;mg PA &#x00026; 400&#x000a0;mg PS per day. </italic><sup>
<italic>a</italic>
</sup><italic>one subject spoke only poor German, three subjects fulfilled the criteria for the high stressed subgroup when no additional subject was needed for this subgroup.</italic></p></caption><graphic xlink:href="1476-511X-13-121-4"/></fig></sec></sec><sec><title>Study design and procedures</title><p>This was a randomized, double-blind, placebo-controlled, single-center study with three treatment arms (placebo, PAS 200, PAS 400 daily for six weeks). The study included four visits at the study site and had a total duration of 44&#x000a0;days for each subject.</p><p>Before subjects were invited to the study site, a first screening took place by telephone interview. Here, subjects received some general information on study procedures as well as a first check of inclusion and exclusion criteria. At visit one (V1), subjects received an extended written information on the aim of this study and all detailed study procedures. After clarifying possible questions, the signed written informed consent was obtained. The study physician then assessed vital signs and took a blood sample for determining safety parameters (i.e. blood profile for hemoglobin, hematocrit, platelet count, leukocytes, monocytes, neutrophils, eosinophils and basophils). Thereafter, subjects completed the Trier Inventory for Chronic Stress (TICS [<xref ref-type="bibr" rid="B43">43</xref>]). Chronic stress was determined using the Screening Scale for Chronic Stress, a subscale of the TICS. For classification of low and high chronic stress, the median value of 13 reported by Schulz and colleagues [<xref ref-type="bibr" rid="B43">43</xref>] was used as a cut off value. Thirty-five HCS and 35 LCS were randomly assigned to one of the three treatment groups. Randomization sequence was stratified with a 1:1 allocation using random blocks of variable sizes with the computer software SPSS 20.0 (IBM Corporation, Somer NY; USA).</p><p>At visit two (V2) those subjects meeting eligibility criteria received a random number. According to the randomization sequence, subjects received their daily supplementation of 4 capsules for the following 21&#x000a0;days. Capsules were packed in a container with a Medication Event Monitoring System (MEMS&#x000ae;) track cap (Aardex Ltd, Zug, Switzerland) to monitor container openings and indicating protocol compliance. MEMS&#x000ae; recorded time and date of each opening electronically. At visit three (V3), MEMS&#x000ae; track caps were read out and subjects received their supplementation dose for the following three weeks. At the final study visit (V4), a post supplementation blood sample for safety parameters was taken and the Trier Social Stress Test (TSST); [<xref ref-type="bibr" rid="B63">63</xref>] was performed to induce an acute psycho-social stressful situation. At V2, V3 and V4 subjects were carefully checked for adverse events and concomitant medication.</p><p>V4 had an overall duration of 180&#x000a0;minutes. Subjects received their last supplement dosage 90&#x000a0;minutes prior to the stress test. Pre- and post-stress psychometrics tests were performed. For HPAA activity measures saliva (free cortisol) and blood (total cortisol) samples were taken at 2&#x000a0;min. prior to the TSST as well as 1&#x000a0;min., 10&#x000a0;min., 20&#x000a0;min., 30&#x000a0;min. and 60&#x000a0;min. after the TSST. Blood samples, taken at 2&#x000a0;min. prior and 1&#x000a0;min. after the TSST, were also used for ACTH analyses.</p><p>Saliva samples were collected using Salivettes&#x000ae; (Sarstedt AG &#x00026; Co., N&#x000fc;mbrecht, Germany). Blood samples were collected using a vein catheter and 2.7&#x000a0;ml EDTA monovettes&#x000ae; (Sarstedt AG &#x00026; Co., N&#x000fc;mbrecht, Germany). Saliva samples were stored at &#x02212;20&#x000b0;C, blood samples were centrifuged and stored at &#x02212;20&#x000b0;C and &#x02212;80&#x000b0;C until all participants completed the study.</p><p>Saliva cortisol levels were analyzed at the laboratory of the University of Trier, Germany using a competitive solid phase time-resolved fluorescence immunoassay with flouromeric end point detection (DELFIA). The intra- and interassay variability was below 10%.</p><p>ACTH was determined using a two-step immunoassay with streptavidin microparticles and electrochemiluminescence detection. Serum cortisol levels were analyzed using an electrochemiluminescence immunoassay (ECLIA). The assay is based on luminescence produced during photochemical reactions in solutions. Both assays used Elecsys&#x000ae; (Roche Diagnostics GmbH, Mannheim, Germany) and their intra- and interassay variability was below 10%.</p><p>For measures of the autonomic nervous system, heart rate and pulse transit time (PTT) were measured continuously from 20&#x000a0;min. prior to the TSST to 20&#x000a0;min. after the TSST using an electrocardiogram device (SOMNOscreen&#x02122; plus, SOMNOmedics GmbH, Randersacker, Germany). PTT is determined by measuring the electrocardiography and the pulse wave at a finger. Studies indicate that PTT is an appropriate parameter for stress measurement [<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B64">64</xref>].</p><p>Psychometric assessment included a mood questionnaire MDBF [<xref ref-type="bibr" rid="B65">65</xref>], before and after the TSST. State anxiety was assessed with the STAI-X1 [<xref ref-type="bibr" rid="B66">66</xref>] before and after the TSST. Furthermore, levels of perceived anxiety, stress and insecurity were measured before, during and after the TSST, as described by Hellhammer and Schubert [<xref ref-type="bibr" rid="B67">67</xref>].</p></sec><sec><title>Study treatment</title><p>The study supplement PAS (produced by Lipogen Ltd, Israel) and sold as &#x0201c;MemreePlus&#x02122;&#x0201d; by Lonza Ltd, Switzerland was administered in capsules. Lipogen holds a patent (US 6,410,522 &#x00026; EP 1201244) and the supplement has an US FDA GRAS (Generally Recognized As Safe) status. In this study, 4 capsules were administered per day: subjects were asked to take two capsules in the morning, one at noon and one in the evening with a glass of water after meals. Single capsules of the PAS 400 group (400&#x000a0;mg PA &#x00026; 400&#x000a0;mg PS per day) consisted of 100&#x000a0;mg phosphatidylserine (PS) and lysophosphatidylserine, 100&#x000a0;mg phosphatidic acid (PA) and lysophosphatidic acid, 235&#x000a0;mg other phospholipids and glycerides, 5&#x000a0;mg silicone dioxide. Single capsules of the PAS 200 group (200&#x000a0;mg PA &#x00026; 200&#x000a0;mg PS per day) consisted of 50&#x000a0;mg phosphatidylserine (PS) and lysophosphatidylserine, 50&#x000a0;mg phosphatidic acid (PA) and lysophosphatidic acid, 335&#x000a0;mg other phospholipids and glycerides, 5&#x000a0;mg silicone dioxide. Placebo capsules contained 435 maize starch and 5&#x000a0;mg silicone dioxide. All capsules were identical in size, shape and colour.</p></sec><sec><title>Stress test</title><p>The Trier Social Stress Test TSST; [<xref ref-type="bibr" rid="B63">63</xref>] was established in 1993 combining key elements of social stress with novelty, unpredictability, uncontrollability and ego-involvement in a standardized laboratory protocol for approximately15 minutes. Since then, it has been used in many clinical studies and in various areas of research. A meta-analysis of stress test protocols of Dickerson and Kemeny [<xref ref-type="bibr" rid="B68">68</xref>] showed that the protocol of the TSST is most effective in provoking HPAA responses. Furthermore, the TSST has been shown to provoke a strong increase in an individual&#x02019;s perception of stress, insecurity and anxiety [<xref ref-type="bibr" rid="B67">67</xref>].</p><p>The TSST protocol compromises an introduction by the study manager: the subject is introduced to a panel and is asked to prepare for a job interview in a new company. After this introduction, the study manager leaves the TSST-room and the subject had a 3-min. period to prepare for the job interview. The 5-min. interview is followed by a 5&#x000a0;min. mental arithmetic task, stepwise subtracting 17 from 2023 as quickly and correctly as possible. The TSST is terminated by the study manager leading the participant back to every participant&#x02019;s individual room. All TSSTs were conducted in the afternoon to control for diurnal cycles.</p></sec><sec><title>Statistical analysis</title><p>For statistical analyses, we used the software SPSS 21 (IBM Corporation, Somer NY, USA). For statistical inference, different statistical tests were performed. Only two-sided tests were used and data were interpreted on an &#x003b1;-level below 5% (&#x003b1;&#x02009;&#x0003c;&#x02009;.05). Baseline characteristics and demographics as well as data violating normality distribution were analyzed using Kruskal Wallis H test.</p><p>For cortisol the area under the curve with respect to ground (AUC<sub>G</sub>) and its increase (AUC<sub>I</sub>) were calculated using the formula described by Pruessner and colleagues [<xref ref-type="bibr" rid="B49">49</xref>]. The AUC<sub>G</sub> holds information about general cortisol levels, as it is an integrated value of all measurements. The AUC<sub>I</sub> holds information about the increase of cortisol levels, as it is an integrated value of all measurements adjusted for the cortisol level under resting conditions. For salivary cortisol AUC<sub>G</sub> and AUC<sub>I</sub> we conducted Kruskal-Wallis-H-tests for effects of treatment groups and Mann&#x02013;Whitney-U-tests for treatment group to treatment group comparison and for effects of chronic stress level. For serum cortisol AUC<sub>G</sub> and AUC<sub>I</sub> we conducted univariate analyses of variance with treatment group and chronic stress level as fixed factors. Post hoc comparison was done with Tukey post hoc testing. For ACTH we conducted repeated measures analyses of variance with treatment group and chronic stress level as factors. Post hoc comparison of treatment groups was done with Tukey post hoc testing. Post hoc comparison of increase differences was done by repeated measures analyses of variance, with analysis-filters for relevant groups.</p></sec></sec><sec><title>Abbreviations</title><p>ACTH: Adrenocorticotropic hormone; AUC<sub>G</sub>: Area under the curve with respect to ground; AUC<sub>I</sub>: Area under the curve with respect to its increase; BMI: Body mass index; CBG: Corticosteroid-binding globulin; CRO: Clinical research organization; DELFIA: Dissociation-enhanced lanthanide fluorescence immunoassay; ECLIA: Electrochemiluminescence immunoassay; EDTA: Ethylendiamintetraacetat; HCS: High chronically stressed subjects; HPAA: Hypothalamic-pituitary-adrenal axis; LCS: Low chronically stressed subjects; MDBF: Multidimensional mood state questionnaire (German: Mehrdimensionaler Befindlichkeitsfragebogen); MEMS: Medication event monitoring system; PA: Phosphatidic acid; PS: Phosphatidylserine; PAS: Phosphatidic acid and phosphatidylserine; PTT: Pulse transit time; SE: Standard error; SPSS: Statistical package for the social sciences; STAI: State trait anxiety inventory; TICS: Trier inventory for chronic stress; TSST: Trier social stress test; V: Visit; VAS: Visual analogue scale; WHR: Waist to hip ratio.</p></sec><sec><title>Competing interests</title><p>This study was financed by Lipogen Ltd (DR) and Lonza Ltd (UF) and performed by Daacro GmbH &#x00026; Co.KG (JH, DV, NF), a clinical research organization. DR, UF disclose a commercial interest. JH, DV, NF declare that they have no competing interest.</p></sec><sec><title>Authors&#x02019; contributions</title><p>JH, UF, DR designed the clinical study protocol. NF managed the study. DV performed the statistical analysis. JH, DV, NF drafted the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgements</title><p>We are grateful to all participants of this study.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="book"><name><surname>Finan</surname><given-names>PH</given-names></name><name><surname>Zautra</surname><given-names>AJ</given-names></name><name><surname>Wershba</surname><given-names>R</given-names></name><person-group person-group-type="editor">Contrada RJ, Baum A</person-group><article-title>The dynamics of emotions in adaptation to stress</article-title><source>The Handbook of Stress Science: Biology, Psychology, and Health</source><year>2011</year><publisher-name>New York: Springer Publishing Company</publisher-name><fpage>209</fpage><lpage>220</lpage></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="book"><name><surname>Dallman</surname><given-names>MF</given-names></name><name><surname>Hellhammer</surname><given-names>DH</given-names></name><source>Regulation of the Hypothalamic-Pituitary-Adrenal Axis, Chronic Stress, and Energy: The Role of Brain Networks</source><year>2010</year><publisher-name>New York: Springer</publisher-name></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Hellhammer</surname><given-names>DH</given-names></name><name><surname>Wade</surname><given-names>S</given-names></name><article-title>Endocrine correlates of stress vulnerability</article-title><source>Psychother Psychosom</source><year>1993</year><volume>60</volume><fpage>8</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">8234641</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Nyuyki</surname><given-names>KD</given-names></name><name><surname>Beiderbeck</surname><given-names>DI</given-names></name><name><surname>Lukas</surname><given-names>M</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>Reber</surname><given-names>SO</given-names></name><article-title>Chronic subordinate colony housing (CSC) as a model of chronic psychosocial stress in male rats</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e52371</fpage><pub-id pub-id-type="pmid">23300653</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Chrousos</surname><given-names>GP</given-names></name><article-title>Stress and disorders of the stress system</article-title><source>Nat Rev Endocrinol</source><year>2009</year><volume>5</volume><fpage>374</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">19488073</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Heim</surname><given-names>C</given-names></name><name><surname>Ehlert</surname><given-names>U</given-names></name><name><surname>Hellhammer</surname><given-names>DH</given-names></name><article-title>The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders</article-title><source>Psychoneuroendocrinology</source><year>2000</year><volume>25</volume><fpage>1</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">10633533</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Fries</surname><given-names>E</given-names></name><name><surname>Hesse</surname><given-names>J</given-names></name><name><surname>Hellhammer</surname><given-names>J</given-names></name><name><surname>Hellhammer</surname><given-names>DH</given-names></name><article-title>A new view on hypocortisolism</article-title><source>Psychoneuroendocrinology</source><year>2005</year><volume>30</volume><fpage>1010</fpage><lpage>1016</lpage><pub-id pub-id-type="pmid">15950390</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Schmidt-Reinwald</surname><given-names>A</given-names></name><name><surname>Pruessner</surname><given-names>JC</given-names></name><name><surname>Hellhammer</surname><given-names>DH</given-names></name><name><surname>Federenko</surname><given-names>I</given-names></name><name><surname>Rohleder</surname><given-names>N</given-names></name><name><surname>Sch&#x000fc;rmeyer</surname><given-names>TH</given-names></name><name><surname>Kirschbaum</surname><given-names>C</given-names></name><article-title>The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm</article-title><source>Life Sci</source><year>1999</year><volume>64</volume><fpage>1653</fpage><lpage>1660</lpage><pub-id pub-id-type="pmid">10328525</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Pruessner</surname><given-names>M</given-names></name><name><surname>Hellhammer</surname><given-names>DH</given-names></name><name><surname>Pruessner</surname><given-names>JC</given-names></name><name><surname>Lupien</surname><given-names>SJ</given-names></name><article-title>Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening</article-title><source>Psychosom Med</source><year>2003</year><volume>65</volume><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">12554820</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Buske-Kirschbaum</surname><given-names>A</given-names></name><name><surname>Von Auer</surname><given-names>K</given-names></name><name><surname>Krieger</surname><given-names>S</given-names></name><name><surname>Weis</surname><given-names>S</given-names></name><name><surname>Rauh</surname><given-names>W</given-names></name><name><surname>Hellhammer</surname><given-names>DH</given-names></name><article-title>Blunted cortisol responses to psychosocial stress in asthmatic children: a general feature of atopic disease</article-title><source>Psychosom Med</source><year>2003</year><volume>65</volume><fpage>806</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">14508024</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Kakiashvili</surname><given-names>T</given-names></name><name><surname>Leszek</surname><given-names>J</given-names></name><name><surname>Rutkowski</surname><given-names>K</given-names></name><article-title>The medical perspective on burnout. International journal of occupational medicine and environmental health</article-title><source>Int J Occup Med Environ Health</source><year>2013</year><volume>26</volume><fpage>401</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">24018996</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Reber</surname><given-names>SO</given-names></name><name><surname>Birkeneder</surname><given-names>L</given-names></name><name><surname>Veenema</surname><given-names>AH</given-names></name><name><surname>Obermeier</surname><given-names>F</given-names></name><name><surname>Falk</surname><given-names>W</given-names></name><name><surname>Straub</surname><given-names>RH</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><article-title>Adrenal insufficiency and colonic inflammation after a novel chronic psycho-socoial stress paradigm in mice: implications and mechanisms</article-title><source>Endocrinology</source><year>2007</year><volume>148</volume><fpage>670</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">17110427</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Schult</surname><given-names>J</given-names></name><name><surname>Hero</surname><given-names>T</given-names></name><name><surname>Hellhammer</surname><given-names>J</given-names></name><article-title>Effects of powdered fertilized eggs on the stress response</article-title><source>Clin Nutr</source><year>2010</year><volume>29</volume><fpage>255</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">19837490</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Schubert</surname><given-names>M</given-names></name><name><surname>Contreras</surname><given-names>C</given-names></name><name><surname>Franz</surname><given-names>N</given-names></name><name><surname>Hellhammer</surname><given-names>J</given-names></name><article-title>Milk-based phospholipids increase morning cortisol availability and improve memory in chronically stressed men</article-title><source>Nutr Res</source><year>2011</year><volume>31</volume><fpage>413</fpage><lpage>420</lpage><pub-id pub-id-type="pmid">21745622</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Hellhammer</surname><given-names>J</given-names></name><name><surname>Hero</surname><given-names>T</given-names></name><name><surname>Franz</surname><given-names>N</given-names></name><name><surname>Contreras</surname><given-names>C</given-names></name><name><surname>Schubert</surname><given-names>M</given-names></name><article-title>Omega-3 fatty acids administered in phosphatidylserine improved certain aspects of high chronic stress in men</article-title><source>Nutr Res</source><year>2012</year><volume>32</volume><fpage>241</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">22575036</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Athenstaedt</surname><given-names>K</given-names></name><name><surname>Daum</surname><given-names>G</given-names></name><article-title>Phosphatidic acid, a key intermediate in lipid metabolism</article-title><source>Eur J Biochem</source><year>1999</year><volume>266</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">10542045</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Kooijman</surname><given-names>EE</given-names></name><name><surname>Chupin</surname><given-names>V</given-names></name><name><surname>De Kruijff</surname><given-names>B</given-names></name><name><surname>Burger</surname><given-names>KN</given-names></name><article-title>Modulation of membrane curvature by phosphatidic acid and lysophosphatidic acid</article-title><source>Traffic</source><year>2003</year><volume>4</volume><fpage>162</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">12656989</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>McMahon</surname><given-names>HT</given-names></name><name><surname>Gallop</surname><given-names>JL</given-names></name><article-title>Membrane curvature and mechanisms of dynamic cell membrane remodelling</article-title><source>Nature</source><year>2005</year><volume>438</volume><fpage>590</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">16319878</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Foster</surname><given-names>DA</given-names></name><article-title>Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells</article-title><source>Biochim Biophys Acta</source><year>2009</year><volume>1791</volume><fpage>949</fpage><lpage>955</lpage><pub-id pub-id-type="pmid">19264150</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Sergeant</surname><given-names>S</given-names></name><name><surname>Waite</surname><given-names>KA</given-names></name><name><surname>Heravi</surname><given-names>J</given-names></name><name><surname>McPhail</surname><given-names>LC</given-names></name><article-title>Phosphatidic acid regulates tyrosine phosphorylating activity in human neutrophils: enhancement of Fgr activity</article-title><source>J Biol Chem</source><year>2000</year><volume>276</volume><fpage>4737</fpage><lpage>4746</lpage><pub-id pub-id-type="pmid">11078731</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Adachi</surname><given-names>M</given-names></name><name><surname>Horiuchi</surname><given-names>G</given-names></name><name><surname>Ikematsu</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Terao</surname><given-names>J</given-names></name><name><surname>Satouchi</surname><given-names>K</given-names></name><name><surname>Tokumura</surname><given-names>A</given-names></name><article-title>Intragastrically administered lysophosphatidic acids protect against gastric ulcer in rats under water-immersion restraint stress</article-title><source>Dig Dis Sci</source><year>2011</year><volume>56</volume><fpage>2252</fpage><lpage>2261</lpage><pub-id pub-id-type="pmid">21298479</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Horiuchi</surname><given-names>G</given-names></name><name><surname>Matsuoka</surname><given-names>M</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><name><surname>Tokumura</surname><given-names>A</given-names></name><name><surname>Koike</surname><given-names>T</given-names></name><name><surname>Satouchi</surname><given-names>K</given-names></name><article-title>Formation of lysophosphatidic acid, a wound-healing lipid, during digestion of cabbage leaves</article-title><source>Biosci Biotechnol Biochem</source><year>2009</year><volume>73</volume><fpage>1293</fpage><lpage>1300</lpage><pub-id pub-id-type="pmid">19502739</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Pasiakos</surname><given-names>SM</given-names></name><article-title>Exercise and amino acid anabolic cell signaling and the regulation of skeletal muscle mass</article-title><source>Nutrients</source><year>2012</year><volume>4</volume><fpage>740</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">22852061</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Benton</surname><given-names>D</given-names></name><name><surname>Donohoe</surname><given-names>RT</given-names></name><name><surname>Sillance</surname><given-names>B</given-names></name><name><surname>Nabb</surname><given-names>S</given-names></name><article-title>The influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor</article-title><source>Nutr Neurosci</source><year>2001</year><volume>4</volume><fpage>169</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">11842886</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Vakhapova</surname><given-names>V</given-names></name><name><surname>Cohen</surname><given-names>T</given-names></name><name><surname>Richter</surname><given-names>Y</given-names></name><name><surname>Herzog</surname><given-names>Y</given-names></name><name><surname>Korczyn</surname><given-names>AD</given-names></name><article-title>Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial</article-title><source>Dement Geriatr Cogn Disord</source><year>2010</year><volume>29</volume><fpage>467</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">20523044</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Kidd</surname><given-names>PM</given-names></name><article-title>Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids</article-title><source>Altern Med Rev</source><year>2007</year><volume>12</volume><fpage>207</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">18072818</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Hellhammer</surname><given-names>J</given-names></name><name><surname>Fries</surname><given-names>E</given-names></name><name><surname>Buss</surname><given-names>C</given-names></name><name><surname>Engert</surname><given-names>V</given-names></name><name><surname>Tuch</surname><given-names>A</given-names></name><name><surname>Rutenberg</surname><given-names>D</given-names></name><name><surname>Hellhammer</surname><given-names>DH</given-names></name><article-title>Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress</article-title><source>Stress</source><year>2004</year><volume>7</volume><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">15512856</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Hellhammer</surname><given-names>J</given-names></name><name><surname>Waladkhani</surname><given-names>A-R</given-names></name><name><surname>Hero</surname><given-names>T</given-names></name><name><surname>Buss</surname><given-names>C</given-names></name><article-title>Effects of milk phospholipid on memory and psychological stress response</article-title><source>Nutr Res</source><year>2010</year><volume>112</volume><fpage>1124</fpage><lpage>1137</lpage></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>McDaniel</surname><given-names>MA</given-names></name><name><surname>Maier</surname><given-names>SF</given-names></name><name><surname>Einstein</surname><given-names>GO</given-names></name><article-title>&#x0201c;Brain-specific&#x0201d; nutrients: a memory cure?</article-title><source>Nutrition</source><year>2003</year><volume>19</volume><fpage>957</fpage><lpage>975</lpage><pub-id pub-id-type="pmid">14624946</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Monteleone</surname><given-names>P</given-names></name><name><surname>Beinat</surname><given-names>L</given-names></name><name><surname>Tanzillo</surname><given-names>C</given-names></name><name><surname>Maj</surname><given-names>M</given-names></name><name><surname>Kemali</surname><given-names>D</given-names></name><article-title>Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans</article-title><source>Neuroendocrinology</source><year>1990</year><volume>52</volume><fpage>243</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">2170852</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Simopoulos</surname><given-names>AP</given-names></name><article-title>Omega-3 fatty acids in inflammation and autoimmune disease</article-title><source>J Am Coll Nutr</source><year>2002</year><volume>21</volume><fpage>495</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">12480795</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Starks</surname><given-names>MA</given-names></name><name><surname>Starks</surname><given-names>SL</given-names></name><name><surname>Kingsley</surname><given-names>M</given-names></name><name><surname>Purpura</surname><given-names>M</given-names></name><name><surname>J&#x000e4;ger</surname><given-names>R</given-names></name><article-title>The effects of phosphatidylserine on endocrine response to moderate intensity exercise</article-title><source>J Int Soc Sports Nutr</source><year>2008</year><volume>5</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18173851</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Monteleone</surname><given-names>P</given-names></name><name><surname>Maj</surname><given-names>M</given-names></name><name><surname>Beinat</surname><given-names>L</given-names></name><name><surname>Natale</surname><given-names>M</given-names></name><name><surname>Kemali</surname><given-names>D</given-names></name><article-title>Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothamamo-pituitary-adrenal axis in healthy men</article-title><source>Eur J Clin Pharmacol</source><year>1992</year><volume>41</volume><fpage>385</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">1325348</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Kingsley</surname><given-names>M</given-names></name><article-title>Effects of phosphatidylserine supplementation on execising humans</article-title><source>Sports Med</source><year>2006</year><volume>36</volume><fpage>657</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">16869708</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>J&#x000e4;ger</surname><given-names>R</given-names></name><name><surname>Purpura</surname><given-names>M</given-names></name><name><surname>Kingsley</surname><given-names>M</given-names></name><article-title>Phospholipids and sports performance</article-title><source>J Int Soc Sports Nutr</source><year>2007</year><volume>4</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17908337</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Appleton</surname><given-names>KM</given-names></name><name><surname>Rogers</surname><given-names>PJ</given-names></name><name><surname>Ness</surname><given-names>AR</given-names></name><article-title>Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials</article-title><source>Nutr Res Rev</source><year>2008</year><volume>21</volume><fpage>13</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">19079852</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Pandey</surname><given-names>NR</given-names></name><name><surname>Sultan</surname><given-names>K</given-names></name><name><surname>Twomey</surname><given-names>E</given-names></name><name><surname>Sparks</surname><given-names>DL</given-names></name><article-title>Phospholipids block nuclear factor-kappa B and tau phosphorylation and inhibit amyloid-beta secretion in human neuroblastoma cells</article-title><source>Neuroscience</source><year>2009</year><volume>164</volume><fpage>1744</fpage><lpage>1753</lpage><pub-id pub-id-type="pmid">19788916</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Peet</surname><given-names>M</given-names></name><name><surname>Stokes</surname><given-names>C</given-names></name><article-title>Omega-3 fatty acids in the treatment of psychiatric disorders</article-title><source>Drugs</source><year>2005</year><volume>65</volume><fpage>1051</fpage><lpage>1059</lpage><pub-id pub-id-type="pmid">15907142</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Hibbeln</surname><given-names>JR</given-names></name><article-title>Fish consumption and major depression</article-title><source>Lancet</source><year>1998</year><volume>351</volume><fpage>1213</fpage><pub-id pub-id-type="pmid">9643729</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="book"><name><surname>Hibbeln</surname><given-names>JR</given-names></name><person-group person-group-type="editor">Simopoulos AP, Bazan NG</person-group><article-title>Depression, Suicide and Deficiencies of Omega-3 Essential Fatty Acids in Modern Diets</article-title><source>Omega-3 Fatty Acids, the Brain and Retina</source><year>2009</year><edition>Volume 99</edition><publisher-name>Basel: Karger</publisher-name><fpage>17</fpage><lpage>30</lpage></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Parker</surname><given-names>G</given-names></name><name><surname>Gibson</surname><given-names>N</given-names></name><name><surname>Brotchie</surname><given-names>H</given-names></name><name><surname>Heruc</surname><given-names>G</given-names></name><name><surname>Rees</surname><given-names>A-M</given-names></name><name><surname>Hadzi-Pavlovic</surname><given-names>D</given-names></name><article-title>Omega-3 fatty acids and mood disorders</article-title><source>Am J Psychiatry</source><year>2006</year><volume>163</volume><fpage>969</fpage><lpage>978</lpage><pub-id pub-id-type="pmid">16741195</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>K&#x000fc;llenberg</surname><given-names>D</given-names></name><name><surname>Taylor</surname><given-names>LA</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Massing</surname><given-names>U</given-names></name><article-title>Health effects of dietary phospholipids</article-title><source>Lipids Health Dis</source><year>2012</year><volume>11</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">22221411</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="book"><name><surname>Schulz</surname><given-names>P</given-names></name><name><surname>Schlotz</surname><given-names>W</given-names></name><name><surname>Becker</surname><given-names>P</given-names></name><source>Das Trierer Inventar zur Erfassung von chronischem Stress-Version 2 (TICS 2)[Trier Inventory for the Assessment of Chronic Stress]</source><year>2004</year><publisher-name>Gottingen, Germany: Hogrefe</publisher-name></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>De Boer</surname><given-names>D</given-names></name><name><surname>Ring</surname><given-names>C</given-names></name><name><surname>Carroll</surname><given-names>D</given-names></name><article-title>Time course and mechanisms of hemoconcentration in response to mental stress</article-title><source>Biol Psychol</source><year>2006</year><volume>72</volume><fpage>318</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">16448738</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Geddes</surname><given-names>L</given-names></name><name><surname>Voelz</surname><given-names>M</given-names></name><name><surname>Babbs</surname><given-names>C</given-names></name><name><surname>Bourland</surname><given-names>J</given-names></name><name><surname>Tacker</surname><given-names>W</given-names></name><article-title>Pulse transit time as an indicator of arterial blood pressure</article-title><source>Psychophysiology</source><year>1981</year><volume>18</volume><fpage>71</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">7465731</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Vlachopoulos</surname><given-names>C</given-names></name><name><surname>Kosmopoulou</surname><given-names>F</given-names></name><name><surname>Alexopoulos</surname><given-names>N</given-names></name><name><surname>Ioakeimidis</surname><given-names>N</given-names></name><name><surname>Siasos</surname><given-names>G</given-names></name><name><surname>Stefanadis</surname><given-names>C</given-names></name><article-title>Acute mental stress has a prolonged unfavorable effect on arterial stiffness and wave reflections</article-title><source>Psychosom Med</source><year>2006</year><volume>68</volume><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">16554388</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Fechir</surname><given-names>M</given-names></name><name><surname>Schlereth</surname><given-names>T</given-names></name><name><surname>Purat</surname><given-names>T</given-names></name><name><surname>Kritzmann</surname><given-names>S</given-names></name><name><surname>Geber</surname><given-names>C</given-names></name><name><surname>Eberle</surname><given-names>T</given-names></name><name><surname>Gamer</surname><given-names>M</given-names></name><name><surname>Birklein</surname><given-names>F</given-names></name><article-title>Patterns of sympathetic responses induced by different stress tasks</article-title><source>Open Neurol J</source><year>2008</year><volume>2</volume><fpage>25</fpage><pub-id pub-id-type="pmid">19018304</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="other"><name><surname>Hey</surname><given-names>S</given-names></name><name><surname>Gharbi</surname><given-names>A</given-names></name><name><surname>Von Haaren</surname><given-names>B</given-names></name><name><surname>Walter</surname><given-names>K</given-names></name><name><surname>Konig</surname><given-names>N</given-names></name><name><surname>Loffler</surname><given-names>S</given-names></name><article-title>Continuous noninvasive pulse transit time measurement for psycho-physiological stress monitoring</article-title><source>eHealth, Telemedicine, and Social Medicine, 2009 eTELEMED&#x02019;09 International Conference on. IEEE</source><year>2009</year><fpage>113</fpage><lpage>116</lpage></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Pruessner</surname><given-names>JC</given-names></name><name><surname>Kirschbaum</surname><given-names>C</given-names></name><name><surname>Meinlschmid</surname><given-names>G</given-names></name><name><surname>Hellhammer</surname><given-names>DH</given-names></name><article-title>Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change</article-title><source>Psychoneuroendocrinology</source><year>2003</year><volume>28</volume><fpage>916</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">12892658</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Pawlow</surname><given-names>LA</given-names></name><name><surname>Jones</surname><given-names>GE</given-names></name><article-title>The impact of abbreviated progressive muscle relaxation on salivary cortisol</article-title><source>Biol Psychol</source><year>2002</year><volume>60</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">12100842</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Matousek</surname><given-names>RH</given-names></name><name><surname>Dobkin</surname><given-names>PL</given-names></name><name><surname>Pruessner</surname><given-names>JC</given-names></name><article-title>Cortisol as a marker for improvement in mindfulness-based stress reduction-</article-title><source>Complement Ther Clin Pract</source><year>2010</year><volume>16</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">20129404</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>MacLean</surname><given-names>CR</given-names></name><name><surname>Walton</surname><given-names>KG</given-names></name><name><surname>Wenneberg</surname><given-names>SR</given-names></name><name><surname>Levitsky</surname><given-names>DK</given-names></name><name><surname>Mandarino</surname><given-names>JV</given-names></name><name><surname>Waziri</surname><given-names>R</given-names></name><name><surname>Hillis</surname><given-names>SL</given-names></name><name><surname>Schneider</surname><given-names>RH</given-names></name><article-title>Effects of the Transcendental Meditation program on adaptive mechanisms: changes in hormone levels and responses to stress after 4&#x000a0;months of practice</article-title><source>Psychoneuroendocrinology</source><year>1997</year><volume>22</volume><fpage>277</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">9226731</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Olff</surname><given-names>M</given-names></name><name><surname>De Vries</surname><given-names>GJ</given-names></name><name><surname>Guzelcan</surname><given-names>Y</given-names></name><name><surname>Assies</surname><given-names>J</given-names></name><name><surname>Gersons</surname><given-names>BP</given-names></name><article-title>Changes in cortisol and DHEA plasma levels afer psychotherapy for PTSD</article-title><source>Psychoneuroendocrinology</source><year>2007</year><volume>32</volume><fpage>619</fpage><lpage>626</lpage><pub-id pub-id-type="pmid">17570603</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Bonifazi</surname><given-names>M</given-names></name><name><surname>Suman</surname><given-names>AL</given-names></name><name><surname>Cambiaggi</surname><given-names>C</given-names></name><name><surname>Felici</surname><given-names>A</given-names></name><name><surname>Grasso</surname><given-names>G</given-names></name><name><surname>Lodi</surname><given-names>L</given-names></name><name><surname>Mencarelli</surname><given-names>M</given-names></name><name><surname>Muscettola</surname><given-names>M</given-names></name><article-title>Changes in salivary cortisol and corticosteroid receptor-alpha mRNA expression following a 3-week multidisciplinary treatment program in patients with fibromyalgia</article-title><source>Psychoneuroendocrinology</source><year>2006</year><volume>31</volume><fpage>1076</fpage><lpage>1086</lpage><pub-id pub-id-type="pmid">16962248</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Mommersteeg</surname><given-names>PM</given-names></name><name><surname>Keijsers</surname><given-names>GP</given-names></name><name><surname>Heijnen</surname><given-names>CJ</given-names></name><name><surname>Verbraak</surname><given-names>MJ</given-names></name><name><surname>van Doornen</surname><given-names>LJ</given-names></name><article-title>Cortisol deviations in people with burnout before and after psychotherapy: a pilot study</article-title><source>Health Psychol</source><year>2006</year><volume>25</volume><fpage>243</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">16569117</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><name><surname>Stefanski</surname><given-names>V</given-names></name><article-title>Social stress in laboratory rats: behavior, immune function, and tumor metastasis</article-title><source>Physiol Behav</source><year>2001</year><volume>73</volume><fpage>385</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">11438366</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><name><surname>Spencer</surname><given-names>RL</given-names></name><name><surname>Miller</surname><given-names>AH</given-names></name><name><surname>Moday</surname><given-names>H</given-names></name><name><surname>McEwen</surname><given-names>BS</given-names></name><name><surname>Blanchard</surname><given-names>RJ</given-names></name><name><surname>Blanchard</surname><given-names>DC</given-names></name><name><surname>Sakai</surname><given-names>RR</given-names></name><article-title>Chronic social stress produces reductions in available splenic type II corticosteroid receptor binding and plasma corticosteroid binding globulin levels</article-title><source>Psychoneuroendocrinology</source><year>1996</year><volume>21</volume><fpage>95</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">8778907</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><name><surname>Stefanski</surname><given-names>V</given-names></name><article-title>Social stress in laboratory rats: hormonal responses and immune cell distribution</article-title><source>Psychoneuroendocrinology</source><year>2000</year><volume>25</volume><fpage>389</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">10725615</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><name><surname>Perogamvros</surname><given-names>I</given-names></name><name><surname>Ray</surname><given-names>DW</given-names></name><name><surname>Trainer</surname><given-names>PJ</given-names></name><article-title>Regulation of cortisol bioavailability&#x02013;effects on hormone measurement and action</article-title><source>Nat Rev Endocrinol</source><year>2012</year><volume>8</volume><fpage>717</fpage><lpage>727</lpage><pub-id pub-id-type="pmid">22890008</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>WL</given-names></name><name><surname>Carrell</surname><given-names>RW</given-names></name><name><surname>Zhou</surname><given-names>A</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><article-title>How changes in affinity of corticosteroid-binding globulin modulate free cortisol concentration</article-title><source>J Clin Endocrinol Metab</source><year>2013</year><volume>98</volume><fpage>3315</fpage><lpage>3322</lpage><pub-id pub-id-type="pmid">23783094</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><name><surname>Moisan</surname><given-names>M-P</given-names></name><article-title>CBG: a cortisol reservoir rather than a transporter</article-title><source>Nat Rev Endocrinol</source><year>2013</year><volume>9</volume><fpage>78</fpage><pub-id pub-id-type="pmid">23296160</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><name><surname>Mavrides</surname><given-names>N</given-names></name><name><surname>Nemeroff</surname><given-names>C</given-names></name><article-title>Treatment of depression in cardiovascular disease</article-title><source>Depress Anxiety</source><year>2013</year><volume>30</volume><fpage>328</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">23293051</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><name><surname>Kirschbaum</surname><given-names>C</given-names></name><name><surname>Pirke</surname><given-names>KM</given-names></name><name><surname>Hellhammer</surname><given-names>DH</given-names></name><article-title>The &#x02018;Trier Social Stress Test&#x02019;-a tool for investigating psychobiological stress responses in a laboratory setting</article-title><source>Neuropsychobiology</source><year>1993</year><volume>28</volume><fpage>76</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">8255414</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="other"><name><surname>Hey</surname><given-names>S</given-names></name><name><surname>Sghir</surname><given-names>H</given-names></name><article-title>Psycho-physiological stress monitoring using mobile and continous pulse transit time measurement</article-title><source>eTELEMED 2011, The Third International Conference on eHealth, Telemedicine, and Social Medicine</source><year>2011</year><fpage>126</fpage><lpage>129</lpage></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="book"><name><surname>Steyer</surname><given-names>R</given-names></name><name><surname>Schwenkmezger</surname><given-names>P</given-names></name><name><surname>Notz</surname><given-names>P</given-names></name><name><surname>Eid</surname><given-names>M</given-names></name><source>MDBF: Der Mehrdimensionale Befindlichkeitsfragebogen</source><year>1997</year><publisher-name>G&#x000f6;ttingen, Germany: Hogrefe</publisher-name></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="book"><name><surname>Laux</surname><given-names>L</given-names></name><name><surname>Glanzmann</surname><given-names>P</given-names></name><name><surname>Schaffner</surname><given-names>P</given-names></name><name><surname>Spielberger</surname><given-names>CD</given-names></name><source>STAI: Das State-Trait-Angstinventar</source><year>1981</year><publisher-name>G&#x000f6;ttingen, Germany: Hogrefe</publisher-name></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><name><surname>Hellhammer</surname><given-names>J</given-names></name><name><surname>Schubert</surname><given-names>M</given-names></name><article-title>The physiological response to Trier Social Stress Test relates to subjective measures of stress during but not before or after the test</article-title><source>Psychoneuroendocrinology</source><year>2012</year><volume>37</volume><fpage>119</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">21689890</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><name><surname>Dickerson</surname><given-names>SS</given-names></name><name><surname>Kemeny</surname><given-names>ME</given-names></name><article-title>Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research</article-title><source>Psychol Bull</source><year>2004</year><volume>130</volume><fpage>355</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">15122924</pub-id></mixed-citation></ref></ref-list></back></article>